Zdrowie i gospodarka · 19/12/2003
FDA Approves Injectable Dosage Form for Flunixin Meglumine Solution
The Food and Drug Administration (FDA) is updating its regulations to allow the prescription use of flunixin meglumine solution for controlling inflammation in horses, beef cattle, and nonlactating dairy cattle, following approval of an abbreviated new animal drug application (ANADA) by Norbrook Laboratories, Ltd.